Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway
X Li, Q Liang, S Gao, Q Jiang, F Zhang, R Zhang… - International …, 2022 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a pathological consequence of interstitial pulmonary
diseases, and is characterized by the persistence of fibroblasts and excessive deposition of …
diseases, and is characterized by the persistence of fibroblasts and excessive deposition of …
Lenalidomide Attenuates Post-Inflammation Pulmonary Fibrosis Through Blocking NF-κB Signaling Pathway
X Li, Q Liang, S Gao, Q Jiang, F Zhang… - Available at SSRN … - papers.ssrn.com
Pulmonary fibrosis is a pathological consequence of interstitial pulmonary diseases, and is
characterized by the persistence of fibroblasts and excessive deposition of extracellular …
characterized by the persistence of fibroblasts and excessive deposition of extracellular …
Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway.
X Li, Q Liang, S Gao, Q Jiang, F Zhang… - International …, 2021 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a pathological consequence of interstitial pulmonary
diseases, and is characterized by the persistence of fibroblasts and excessive deposition of …
diseases, and is characterized by the persistence of fibroblasts and excessive deposition of …
Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway
X Li, Q Liang, S Gao, Q Jiang… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a pathological consequence of interstitial pulmonary
diseases, and is characterized by the persistence of fibroblasts and excessive deposition of …
diseases, and is characterized by the persistence of fibroblasts and excessive deposition of …